NUCLEIC ACID STRUCTURE AND REACTIVITY
核酸结构和反应性
基本信息
- 批准号:2701500
- 负责人:
- 金额:$ 27.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1980
- 资助国家:美国
- 起止时间:1980-08-01 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:RNA directed DNA polymerase RNA splicing Saccharomyces Tetrahymena aminoacyltransferase conformation enzyme mechanism enzyme structure microorganism genetics molecular cloning nucleic acid sequence nucleic acid structure protein binding protein reconstitution ribonucleoproteins ribozymes telomerase telomere
项目摘要
The long-term goals of this project are to contribute to the
understanding of (1) how structured RNA molecules can catalyze
biochemical reactions in the absence of proteins, and (2) how RNA
participates in catalysis in concert with proteins.
In the first broad area, the crystal structure of a domain of the
Tetrahymena group I ribozyme will be used to design and interpret
biochemical studies of RNA tertiary structure formation. The structural
basis of a conformational change involved in switching from step 1 to
step 2 of RNA self-splicing will be investigated. Finally, the structure
and mechanism of a peptidyl transferase ribozyme will be analyzed.
Structure-function relationships in ribozymes are related to health
because RNA viruses, retroviruses, and cellular mRNAs involved in
disease require specific RNA structures.
The second broad area concerns telomerase, the RNA-protein (RNP) enzyme
required for chromosome end replication in diverse eukaryotes. Studies
of telomerase structure and assembly in Saccharomyces cerevisiae and
Schizosaccharomyces pombe will integrate genetic and biochemical
approaches. A major focus is the Telomerase Reverse Transcriptase (TRT)
subunit (known in S. cerevisiae as Ever Shorter Telomeres 2), implicated
as the catalytic subunit of telomerase in many organisms including
humans. Reconstitution of active telomerase RNP from purified
recombinant components and understanding interactions of telomerase with
its telomeric substrate present as a DNA-protein complex are major
goals. Because telomerase is inactive in most human somatic cells but
reactivated in most tumors, analysis of this enzyme may contribute to
development of anti-telomerase chemotherapeutics.
该项目的长期目标是促进
理解(1)结构化RNA分子如何催化
在没有蛋白质的情况下的生化反应,以及(2)RNA如何
与蛋白质一起参与催化作用。
在第一个宽区域中,晶体结构的域的晶体结构,
四膜虫组I核酶将用于设计和解释
RNA三级结构形成的生物化学研究。 结构性
从步骤1转换到步骤2所涉及的构象变化的基础
将研究RNA自剪接的步骤2。最后,结构
并分析肽基转移酶核酶的作用机理。
核酶的结构-功能关系与健康有关
因为RNA病毒、逆转录病毒和细胞mRNA参与了
疾病需要特定的RNA结构。
第二个广泛的领域涉及端粒酶,RNA蛋白(RNP)酶
在不同的真核生物中染色体末端复制所必需的。 研究
端粒酶的结构和组装在酿酒酵母和
粟酒裂殖酵母将整合遗传和生化
接近。 一个主要的焦点是端粒酶逆转录酶(TRT)
亚基(S.酿酒酵母作为越来越短的端粒2),牵连
作为端粒酶的催化亚单位,在许多生物体中,
人类 从纯化的端粒酶RNP中重建活性端粒酶RNP
重组成分和理解端粒酶与
其端粒底物主要以DNA-蛋白质复合物形式存在
目标. 因为端粒酶在大多数人体细胞中是无活性的,
在大多数肿瘤中重新激活,这种酶的分析可能有助于
抗端粒酶化疗药物的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(19)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS ROBERT CECH其他文献
THOMAS ROBERT CECH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS ROBERT CECH', 18)}}的其他基金
Functional Interactions of Telomere Protein with Human Telomerase
端粒蛋白与人端粒酶的功能相互作用
- 批准号:
8458952 - 财政年份:2012
- 资助金额:
$ 27.78万 - 项目类别:
Functional Interactions of Telomere Protein with Human Telomerase
端粒蛋白与人端粒酶的功能相互作用
- 批准号:
8788935 - 财政年份:2012
- 资助金额:
$ 27.78万 - 项目类别:
Functional Interactions of Telomere Protein with Human Telomerase
端粒蛋白与人端粒酶的功能相互作用
- 批准号:
8215956 - 财政年份:2012
- 资助金额:
$ 27.78万 - 项目类别:
TERT Promoter Mutations and Telomerase Reactivation in Cancer Cells
癌细胞中的 TERT 启动子突变和端粒酶重新激活
- 批准号:
9024062 - 财政年份:2012
- 资助金额:
$ 27.78万 - 项目类别:
University of Colorado Systems Biotechnology Building
科罗拉多大学系统生物技术大楼
- 批准号:
7897514 - 财政年份:2010
- 资助金额:
$ 27.78万 - 项目类别:
相似海外基金
Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
- 批准号:
10623834 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246530 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
- 批准号:
2246531 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Standard Grant
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
- 批准号:
2882792 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Studentship
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
- 批准号:
23K18260 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
- 批准号:
10722782 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
- 批准号:
23H02688 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
- 批准号:
10785159 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
- 批准号:
10729566 - 财政年份:2023
- 资助金额:
$ 27.78万 - 项目类别:
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
- 批准号:
10650417 - 财政年份:2022
- 资助金额:
$ 27.78万 - 项目类别: